272 related articles for article (PubMed ID: 26497367)
1. miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
Chen Z; Liu S; Tian L; Wu M; Ai F; Tang W; Zhao L; Ding J; Zhang L; Tang A
Oncotarget; 2015 Nov; 6(35):38139-50. PubMed ID: 26497367
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
Wang H; Wu J; Meng X; Ying X; Zuo Y; Liu R; Pan Z; Kang T; Huang W
Carcinogenesis; 2011 Jul; 32(7):1033-42. PubMed ID: 21565830
[TBL] [Abstract][Full Text] [Related]
3. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
[TBL] [Abstract][Full Text] [Related]
4. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.
Xi ZW; Xin SY; Zhou LQ; Yuan HX; Wang Q; Chen KX
World J Gastroenterol; 2015 May; 21(18):5454-64. PubMed ID: 25987767
[TBL] [Abstract][Full Text] [Related]
8. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
9. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
11. MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
Lin Y; Chen Z; Lin S; Zheng Y; Liu Y; Gao J; Chen S
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):598-606. PubMed ID: 31058289
[TBL] [Abstract][Full Text] [Related]
12. MiR-106b-5p regulates the migration and invasion of colorectal cancer cells by targeting FAT4.
Pan M; Chen Q; Lu Y; Wei F; Chen C; Tang G; Huang H
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33063118
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
14. miR-539 inhibits human colorectal cancer progression by targeting RUNX2.
Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
Biomed Pharmacother; 2017 Nov; 95():1314-1320. PubMed ID: 28938522
[TBL] [Abstract][Full Text] [Related]
15. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
16. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.
Wang ZS; Zhong M; Bian YH; Mu YF; Qin SL; Yu MH; Qin J
Oncotarget; 2016 Jul; 7(28):44266-44276. PubMed ID: 27329595
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
19. miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1.
Li W; Chen A; Xiong L; Chen T; Tao F; Lu Y; He Q; Zhao L; Ou R; Xu Y
Tumour Biol; 2017 May; 39(5):1010428317698389. PubMed ID: 28466778
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
